Vol. 3 No. 1 (2025)

Articles

• Biomaterials in Organoid Research: Design Principles, Functional Regulation, and Clinical Translation

  Wenjing Gao, Baohua Zhong, Yuehua Xu, Zhiyuan Lan

  1-30

  • PDF

• NIH Shift Away from Animal-Only Research Signals a Major Opportunity for Organoids

  ISoOR Insight Team

  • PDF

• ISoOR Gains ILAC Stakeholder Status: Advancing Global Standards in Organoid Biobanking

  ISoOR Insight Team

  • PDF

• Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025

  ISoOR Insight Team

  • PDF

• Development of Patient-Derived Organoids from NUT Carcinoma: A Robust and Fully Documented Culture System

  Mingzhu Yin, Chongyang Shen, Minghui Zhang, Xin Li, Zhuomiao Ye, Liang Dong, Jun Fu

  • PDF

• United Kingdom Launches £75 Million National Roadmap to Phase Out Animal Testing by 2030: A Defining Moment for Human-Relevant Research

  ISoOR Insight Team

  • PDF

• Major Shift in U.S. Research Policy: CDC to End All Nonhuman Primate Experiments by 31 December 2025

  ISoOR Insight Team

  • PDF